Hematology/Oncology

Top Story

Pediatric regimens for ALL show promise in adults

Pediatric regimens for ALL show promise in adults
August 25, 2016

There are several areas of research interest related to the management of young adults with acute lymphoblastic leukemia that stand to impact these patients’ prognosis, according to Ryan D. Cassaday, MD, of Fred Hutchinson Cancer Research Center, the University of Washington School of Medicine and the Seattle Cancer Care Alliance.

“One of the bigger questions right now is what the optimal chemotherapy regimen is,” Cassady said. “There has been a lot of movement recently toward incorporating pediatric regimens into the standard approach to the treatment of young adults.”

Health Canada approves radiopaque bead for HCC, CRC liver metastases

August 25, 2016
BTG International Canada Inc. announced it received Health Canada approval for DC Bead Lumi. The bead is the first such device available commercially for patients with…
In the Journals

High drug prices result of government protection in US

August 25, 2016
The high cost of prescription drugs in the United States is the result of drug manufacturers being granted government-protected monopolies, according to data published…
In the Journals Plus

Studies review extent, disclosure of industry relationships

August 25, 2016
More than two-thirds of the authors of National Comprehensive Cancer Network clinical practice guidelines reported at least one financial conflict of interest, according…

$1 million gift establishes professorship in women’s cancers at City of Hope

August 25, 2016
A $1 million gift has established an endowed professorship in City of Hope’s women’s cancers program. Joanne Mortimer, MD, director of City of…
More News Headlines »
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Video
At Issue

VIDEO: Immune checkpoint inhibitors show promise in metastatic, triple-negative breast cancer

August 9, 2016
More »
Featured
Discoveries from ASCO 2016: Breast Cancer

Discoveries from ASCO 2016: Breast Cancer

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan